Editorial
Accepted on 01 Apr 2025
Editorial: Bridging Molecular Targets and Neural Circuits in Psychiatric Therapeutics
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601881
Type at least 3 characters
2,367 articles
Articles
Review
Accepted on 01 Apr 2025
The roles of extracellular vesicles in mental disorders: information carriers, biomarkers, therapeutic agents
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591469
Original Research
Published on 01 Apr 2025
Increase of Brivaracetam serum concentration with introduction of Cenobamate
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571376
- 183 views
Original Research
Published on 01 Apr 2025
A novel antidepressant mechanism of baicalin: enhancing KIF5A-mediated axoplasmic transport and vesicular trafficking in glutamatergic neurons
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577676
- 189 views
Original Research
Published on 01 Apr 2025
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561020
- 207 views
Original Research
Accepted on 31 Mar 2025
Significant hindlimb static weight-bearing asymmetry persists for 40weeks in a longitudinal study in two widely used rat models of surgically induced osteoarthritis knee pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1560265
Original Research
Accepted on 31 Mar 2025
Preventive Beneficial Effects of Cannabidiol in a Reserpine-Induced Progressive Model of Parkinsonism
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1539783
Systematic Review
Accepted on 31 Mar 2025
Research trends on neutrophil extracellular traps in ischemic stroke: a scientific metrology study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537566
Correction
Published on 31 Mar 2025
Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592653
- 131 views
Original Research
Published on 31 Mar 2025
BAM8-22 targets spinal MrgC receptors to modulate UPRmt activity in the mechanism of bone cancer pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575733
- 188 views
Original Research
Accepted on 28 Mar 2025
Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1581320
Original Research
Accepted on 28 Mar 2025
Computational drug repurposing in Parkinson's disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1539032
Systematic Review
Published on 28 Mar 2025
Effect and safety of perioperative ketamine/esketamine administration on postoperative pain and depression after breast cancer surgery: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532524
- 248 views
Editorial
Accepted on 27 Mar 2025
Editorial: Neuropharmacological Intervention for Severe Mental Illness and Suicide Prevention
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1599083
Systematic Review
Published on 27 Mar 2025
Effects of natural extracts in cognitive function of healthy adults: a systematic review and network meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573034
- 215 views
Review
Published on 26 Mar 2025
Exosomes: an innovative therapeutic target for cerebral ischemia-reperfusion injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1552500
- 220 views